Amylyx Pharmaceuticals, Inc.

Nasdaq:AMLX

Pharmaceutical Preparations·CAMBRIDGE, MA

Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.

Credit & Agreementsmaterial agreements · debt obligations

Credit & Agreements (8-K)

4 shown

Filed	Description
9/10/25	1.01 Material Agreement	→
1/10/25	1.01 Material Agreement	→
6/21/24	1.01 Material Agreement	→
12/6/22	1.01 Material Agreement	→

Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.